ALEC (STOCKS)
Alector, Inc. Common Stock
$1.920000
-0.030000 (-1.54%)
Prev close: $1.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arnon Rosenthal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $210.12M
- Employees
- 163
- P/E (TTM)
- -1.79
- P/B (TTM)
- 3.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
7
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.34 | $-0.42 | +0.0757 | +18.21% |
|
Jun 2025 (Q2)
|
$-0.30 | $-0.47 | +0.1692 | +36.06% |
|
Mar 2025 (Q1)
|
$-0.41 | $-0.49 | +0.0847 | +17.12% |
|
Dec 2024 (Q4)
|
$-0.02 | $-0.65 | +0.6294 | +96.92% |
Financial Statements
| Revenues | $69.09M |
| Benefits Costs and Expenses | $176.76M |
| Costs And Expenses | $176.76M |
| Operating Expenses | $192.74M |
| Depreciation and Amortization | $5.79M |
| Research and Development | $137.06M |
| Other Operating Expenses | $49.88M |
| Operating Income/Loss | -$123.69M |
| Income/Loss From Continuing Operations After Tax | -$107.72M |
| Income/Loss From Continuing Operations Before Tax | -$107.67M |
| Income Tax Expense/Benefit | $48.00K |
| Net Income/Loss | -$107.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$107.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$107.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.06 |
| Diluted Earnings Per Share | -$1.06 |
| Basic Average Shares | 101,381,935 |
| Diluted Average Shares | 101,381,935 |
| Assets | $335.29M |
| Current Assets | $300.39M |
| Noncurrent Assets | $34.90M |
| Fixed Assets | $12.71M |
| Other Non-current Assets | $22.19M |
| Liabilities | $277.57M |
| Current Liabilities | $79.96M |
| Accounts Payable | $4.76M |
| Other Current Liabilities | $75.21M |
| Noncurrent Liabilities | $197.61M |
| Equity | $57.71M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $57.71M |
| Liabilities And Equity | $335.29M |
| Net Cash Flow From Operating Activities | -$197.37M |
| Net Cash Flow From Operating Activities, Continuing | -$197.37M |
| Net Cash Flow From Investing Activities | $212.40M |
| Net Cash Flow From Investing Activities, Continuing | $212.40M |
| Net Cash Flow From Financing Activities | $24.61M |
| Net Cash Flow From Financing Activities, Continuing | $24.61M |
| Net Cash Flow | $39.64M |
| Net Cash Flow, Continuing | $39.64M |
| Comprehensive Income/Loss | -$108.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$108.47M |
| Other Comprehensive Income/Loss | -$734.00K |
| Other Comprehensive Income/Loss Attributable To Parent | -$734.00K |